01 5VERTEX PHARMS INC
01 510206877
01 5Blank
01 5Y
01 52035-04-14
Patent Expiration Date : 2035-04-14
IVACAFTOR; IVACAFTOR, TEZACAFTOR
US Patent Number : 10206877
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 210491
Patent Use Code : U-3026
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2035-04-14
Patent Expiration Date : 2035-04-14
IVACAFTOR; IVACAFTOR, TEZACAFTOR
US Patent Number : 10206877
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 210491
Patent Use Code : U-3027
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2035-04-14
Patent Expiration Date : 2035-04-14
DEUTIVACAFTOR; TEZACAFTOR; VANZACAFTOR CALCIUM
US Patent Number : 10206877
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 218730
Patent Use Code : U-4092
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2035-04-14
Patent Expiration Date : 2035-04-14
IVACAFTOR; IVACAFTOR, TEZACAFTOR
US Patent Number : 10206877
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 210491
Patent Use Code : U-3027
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2035-04-14
Patent Expiration Date : 2035-04-14
IVACAFTOR; IVACAFTOR, TEZACAFTOR
US Patent Number : 10206877
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 210491
Patent Use Code : U-3026
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2035-04-14
